61 It demonstrated that treatment with intravenous tirofiban in comparison to placebo before EVT resulted in no significant difference in functional outcomes at 90 days and noted a nonsignificant trend toward ICH. 61 In the INSPIRE (Intraarterial Versus Intravenous Tirofiban as an Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke) study, Yang et al retrospectively explored the use of intra‐arterial versus intravenous tirofiban during EVT in acute ischemic stroke. 62 It demons
← all excerpts
Management of Incomplete Microcirculatory Reperfusion After Endovascular Thrombectomy: Focus on Inhibition of the Glycoprotein IIb/IIIa Receptor Pathway.
1
—
—